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A photoactivatable Src homology 2 (SH2) domain†
X. Song,a X. Shang,a T. Ju,a R. Cerny,a W. Niu*b and J. Guo*a
Src homology 2 (SH2) domains bind specifically to phosphotyrosine-containing motifs. As a regulatory
module of intracellular signaling cascades, the SH2 domain plays important roles in the signal
transduction of receptor tyrosine kinase pathways. In this work, we reported the construction of
a photoactivatable SH2 domain through the combination of protein engineering and genetic
incorporation of photo-caged unnatural amino acids. Significantly enhanced recognition of
a phosphotyrosine-containing peptide substrate by the engineered SH2 domain mutant was observed
after light-induced removal of the photo-caging group. Optical activation allows the control of protein
and/or cellular function with temporal and spatial resolution. This photoactivatable SH2 domain could
potentially be applied to the study of tyrosine phsophorylation-associated biological processes.
1. Introduction
Src homology 2 (SH2) domains represent the largest class of
known phosphotyrosine (pTyr)-binding domains.1,2 A typical
human cell is estimated to contain 120 non-redundant SH2
domains in 111 unique proteins, including kinases, phos-
phatases, cytoskeletal proteins, regulators of small GTPases,
etc. The recognition of pTyr-containing proteins (phospho-
proteins) or peptides (phosphopeptides) by SH2 domains is
generally in a sequence-specic and phosphorylation-
dependent manner. Phosphopeptides of optimal sequence
bind to their cognate SH2 domains with dissociation
constants in the range of 0.05–0.5 mM. Such specic inter-
actions between SH2 domains and their phosphorylated
partners are essential in the activation or the deactivation of
protein functions and/or cellular processes.
Here we report the construction of a photoactivatable SH2
domain through protein engineering and the genetic incor-
poration of photo-caged unnatural amino acid (Fig. 1 and 2).
It represents the rst example that the function of a SH2
domain can be turned on by light. Such conditional control
of SH2 domain function would not only facilitate investiga-
tions of SH2 domain-associated cellular events, but also
provide an optogenetic tool to regulate an intracellular
signaling cascade of interest. Light activation strategy
provides spatial and temporal resolution on the activation
and/or deactivation of cellular function.
2. Experimental
2.1 Materials and general methods
Chemicals were purchased from Sigma or Fisher Scientic.
Peptides were purchased from NeoBioLab, Inc. Primers were
ordered from Sigma. Restriction enzymes, T4 DNA ligase, and
Antarctic phosphatase (AP) were purchased from New England
Biolabs. KOD hot start DNA polymerase was purchased from
EMD Millipore. Standard molecular biology techniques3 were
used throughout. DNA sequencing analyses were conducted by
Eurons Genomics. Site-directed mutagenesis was carried out
using overlapping PCR. E. coli GeneHogs (Life Technologies)
were used for routine cloning, DNA propagation, and protein
expression. Plasmid preparation and DNA extraction kits were
purchased from Zymo Research. All solutions were prepared in
Fig. 1 A photoactivatable Src homology 2 (SH2) domain. The Src SH2
domain (PDB 1SPS) is shown in green. The phosphorylated peptide
substrate is shown in yellow. The photo-caging group is shown as an
orange circle. pTyr, phosphotyrosine.
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deionized water further treated by Barnstead Nanopure®
ultrapure water purication system. Antibiotics were added
where appropriate to following nal concentrations: kana-
mycin, 50 mg L1; chloramphenicol, 34 mg L1. The synthesis
procedure for ONBK can be found in ESI.†
2.2 Screening of aminoacyl-tRNA synthetase
In a typical experiment, two tubes of E. coli GeneHogs cells
harboring plasmid pLei-GFPUV-Asn149TAG and a pBK-PylRS
variant of interest were grown in 5 mL LB media containing
kanamycin and chloramphenicol at 37 C. The protein expres-
sions were induced at the OD600 of 0.6 by the addition of iso-
propyl-b-D-thiogalactopyranoside (IPTG; 0.25 mM). ONBK was
added to one of the two culture tubes to a nal concentration of
1 mM. Aer an additional 16 h of cultivation, 1 mL of cell
culture from each tube was collected, washed, and resuspended
in 1 mL of potassium phosphate buffer (50 mM, pH 7.4). The
two samples were subsequently used for uorescence and cell
density measurements using a Synergy™ H1 Hybrid plate
reader (BioTek Instruments). The uorescence of GFPUV was
monitored at lEx ¼ 390 nm and lEm ¼ 510 nm. The cell density
was estimated by measuring the sample absorbance at 600 nm.
Values of uorescence intensity were normalized to cell growth.
Using the same set of experimental procedures, previously re-
ported pyrrolysyl-tRNA synthetase (PylRS) mutants were
screened for their ability to incorporate ONBK.
2.3 Construction of plasmids
Four plasmids, pSH2-Arg35TAG, pSH2-Arg35Lys, pSH2-
Arg35TAG-tm, and pSH2-Arg35Lys-tm were constructed. The
SH2 domain-encoding gene was amplied from pET30b-Src4
using primer P1 and P4 (ESI†). The Arg35TAG mutation was
introduced by overlapping PCR using primers P2 and P3 (ESI†).
Digestion of the PCR product followed by ligation into the NdeI
and XhoI sites of pLei vector5 afforded plasmid pSH2-Arg35TAG.
Plasmid pSH2-Arg35Lys was constructed following the same
procedure. The Arg35Lys mutation was introduced by over-
lapping PCR using primers P2 and P5 (ESI†). The introduction
of Thr40Val, Cys45Ala, and Lys63Leu mutations was carried out
by site-directed mutagenesis using primers P6–P9 (ESI†). All the
SH2 domain variants were conrmed by DNA sequencing.
2.4 Protein expression and purication
For the expression of SH2 domain that contains ONBK,
E. coli GeneHogs cells harboring pBK-TocKRS and pSH2-
Arg35TAG (or pSH2-Arg35TAG-tm) were cultured in 100 mL of
LB medium with kanamycin and chloramphenicol at 37 C.
When the OD600 of the culture reached 1.0, the protein
expression was induced by the addition of IPTG and ONBK to
a nal concentration of 0.25 mM and 1 mM, respectively. Aer
24 h of cultivation at room temperature, cells were collected by
centrifugation (5 000g, 10 min), resuspended in lysis buffer
(20 mM potassium phosphate, pH 7.4, 150 mM NaCl, and
20 mM imidazole), and disrupted by sonication. Cellular debris
was removed by centrifugation (21 000g, 30 min, 4 C). The cell-
free lysate was applied to Ni Sepharose 6 Fast Flow resin
(GE Healthcare). Protein purication followed manufacture's
instructions. Puried protein was eluted off the Amicon Econo-
Pac® 10DG desalting column (BioRad Laboratories, Inc) using
storage buffer that contains Tris–HCl (25 mM, pH 7.5), NaCl
(150 mM), and glycerol (5%).
The same procedure was applied to the expression of SH2
domains containing the Arg35Lys mutation (SH2-Arg35Lys and
SH2-Arg35Lys-tm) with the exception that plasmid pBK-TocKRS
was not included in the protein expression strains and ONBK
was not added to the culture media.
2.5 De-caging
An aliquot of SH2 domain protein (22.2 mM) was irradiated by
handheld UV illuminator for 0 min, 15 min, 30 min, or 60 min
at 365 nm (or 302 nm). During the irradiation, the protein
samples were chilled on ice to avoid extensive heating from UV
light.
2.6 Fluorescence polarization (FP) assay
The uorescein-labeled peptide probe was dissolved in assay
buffer containing potassium phosphate (20 mM, pH 7.35), NaCl
(100 mM), DTT (2 mM), and bovine gamma globulin (0.1%).
Aliquot of the peptide solution was distributed in 96-well uo-
rescence plate (Corning Costar 3915) to reach a nal concen-
tration of 10 nM. Aer the addition of indicated amounts of
a SH2 domain variant of interest (20 mM), the assay solution was
gently mixed and incubated at room temperature in the dark for
25 minutes. Fluorescence polarization measurements were
performed on a Synergy™ H1 hybrid plate reader (BioTek
Instruments, Inc) equipped with lter cube (lEx¼ 485 nm, BP¼
20 nm; lEm¼ 528 nm, BP¼ 20 nm). A standard sample layout in
Fig. 2 Genetic incorporation of ONBK into GFPUV-Asn149 mutant. (A)
The structure of ONBK; (B) GFPUV fluorescence assays. Fluorescence
intensity was normalized to cell growth; (C) SDS-PAGE analysis of
GFPUV-Asn149 expression. Lane M, molecular weight marker; lane 1,
with ONBK; lane 2, without ONBK. ONBK, o-nitrobenzyl-oxycarbonyl-
N3-L-lysine.
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96-well plate was designed so that a single plate contains all the
samples for one SH2 domain variant. Triplet samples of each
protein concentration were arrayed in the plate, together with
control samples containing either only the SH2 mutant protein
or peptide probe. Fluorescence intensity data were exported,
converted into anisotropy values. Calculation of the percentage
of bound probe followed reported method.6 Dissociation
constants were calculated by curve tting into one-site specic
binding equation with Hill slope using GraphPad Prism 5
(GraphPad Soware, Inc). Fluorescence polarization assays of
all SH2 domain variants were repeated three times. Results were
reported as the average with standard deviation.
3. Results and discussion
3.1 General approach and rationale
In order to control the affinity between an SH2 domain and its
binding partner, key interaction(s) between the two entities
need(s) to be manipulated. It is known that the pTyr residue
makes a major contribution to the binding free energy (DG) of
a phosphopeptide to its cognate SH2 domain.7We also observed
that the dissociation constant between the Src SH2 domain
(from the proto-oncogene tyrosine-protein kinase Src) and its
peptide substrate was highly dependent on the phosphorylation
state of a tyrosine residue. With phosphorylation of the tyro-
sine, the KD value was in the range of 0.061  0.008 mM.4 In
contrast, the actual KD value (>15 mM) was too large to be
accurately measured when the peptide substrate was not
phosphorylated. Indeed, electrostatic forces between the two
positively charged Arginine (Arg) residues of the SH2 domain
(e.g., Arg15 and Arg35 in the Src SH2 domain)8,9 and the nega-
tively charged pTyr residue of the peptide substrate are the key
interactions. Besides the pTyr residue, the two Arg residues,
which are highly conserved in all known human SH2
sequences,10 do not have any apparent interactions with other
part of the peptide substrate.8,9 We hypothesized that the
interaction between SH2 domain and its binding partner could
be largely abolished if the two Arg residues are masked with
uncharged photo-caging groups. Aer light-induced cleavage of
the caging group, the restoration of the two Arg residues would
yield a functional SH2 domain (Fig. 1).
Since the simultaneous introduction of two bulky photo-
caging groups may impose signicant structural distortion of
an SH2 domain, we decided to mask only one of the two Arg
residues. We envisaged that the loss of a single Arg residue
would still considerably weaken the recognition of pTyr by the
SH2 domain. In fact, we demonstrated that high affinity
binding of pTyr by Src SH2 domain required the presence of
both Arg15 and Arg35 residues. According to our measure-
ments, the Arg15Gln mutant and the Arg35Gln mutant dis-
played nearly 40-fold lower affinity towards a phosphopeptide
probe (Fig. 3A) than that of the wild-type SH2 domain. In
addition to the loss of a positive charge, the installation of
a caged-Arg may further impair the function of SH2 domain due
to the bulkiness of the caging group.
As the genetic incorporation of photo-caged Arg has not been
developed, we decided to use a photo-caged lysine (Lys) instead.
Both Arg and Lys are positively charged amino acids. While the
side chain of Lys is shorter than that of Arg, it is possible that
the replacement of an Arg residue with a Lys residue may not
signicantly affect the function of a SH2 domain. Indeed, the
SH2-Arg35Lys mutant showed a similar affinity (KD ¼ 0.117 mM)
to that (KD ¼ 0.061 mM) of the wild-type SH2 domain (SH2-wt).
On the other hand, mutation at position Arg15 afforded a less
active SH2 domain variant (unpublished data). Therefore, we
focused on the engineering of the SH2-Arg35Lys mutant in this
work. Unmasking of a photo-caged lysine at position 35 would
afford a functional SH2 domain.
3.2 Genetic incorporation of a photo-caged lysine
A previously reported photo-caged lysine, o-nitrobenzyl-oxy-
carbonyl-N3-L-lysine (ONBK; Fig. 2A),11 was employed in this
work. The ortho-nitrobenzyl group represents one of the most
frequently used photo-caging groups in biological experiments.
It is chemically inert in living cells and has a good quantum
yield of de-caging within a short timescale. Furthermore, the de-
caging of the ortho-nitrobenzyl group can be achieved using
a near visible UV light (e.g., 365 nm), which is generally
considered as safe to proteins and cells.
Genetic incorporation of ONBK into proteins in response to
amber nonsense codon in E. coli was reported.11 In order to
replace Arg35 with ONBK, the codon of Arg35 was mutated into
an amber nonsense codon. By using the evolved ONBK-specic
pyrrolysyl-tRNA synthetase mutant (NBK-1)11 together with its
cognate amber suppressor tRNA (tRNACUA), the desired SH2
domain mutant, SH2-Arg35ONBK, was obtained. However, the
protein yield (less than 0.2 mg L1) was not to our satisfaction.
Fig. 3 Recognition of phosphopeptide by the SH2-Arg35ONBK
mutant with and without UV irradiation. (A) The structure of the
phosphopeptide. (B) Fluorescence polarization assay. Each data point
is the average of triplicate measurements with standard deviation.
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While a series of different cultivation conditions were exam-
ined, no signicant improvement in protein yield could be ob-
tained. We concluded that the activity of NBK-1 was the likely
limiting factor in the expression of SH2-Arg35ONBK.
In order to improve the expression level of SH2-Arg35ONBK,
we subsequently screened a library of previously evolved
pyrrolysyl-tRNA synthetase (PylRS) variants. A uorescence-
based screening assay was used to gauge the catalytic activity
of PylRS variants in the aminoacylation of tRNACUA with ONBK.
The amber suppression efficiency was directly linked to the
expression level of a GFPUV mutant (GFPUV-Asn149TAG)11 that
contains an amber nonsense codon at position Asn149. Among
all the PylRS variants examined (Fig. S1, ESI†), DizPKRS,12
BhcKRS,13 and TcokRS,14 showed excellent efficiency in the
incorporation of ONBK into GFPUV-Asn149 mutant protein in
response to amber nonsense codon (Fig. 2B). Based on the
uorescence assay (Fig. S1, ESI†), the DizPKRS, BhcKRS, and
TcokRS mutants displayed about 68, 100, and 116 folds higher
efficiency in ONBK incorporation than that of the reported
NBK-1 mutant, respectively. Furthermore, notable GFP uo-
rescence was only observed in the presence of ONBK for all
three PylRS variants (Fig. 2B). This result indicates that these
PylRS variants only charge tRNACUA with ONBK but not with any
of the endogenous natural amino acids in E. coli. Among the
three hits, TcokRS showed the best delity and efficiency
towards ONBK. Subsequent SDS-PAGE analysis (Fig. 2C)
conrmed the conclusion of the uorescence-based assay.
Therefore, TcokRS was selected for the genetic incorporation of
ONBK into SH2 domain mutants in this work.
3.3 The rst generation SH2 domain mutant
The expression of the SH2-Arg35ONBK mutant (encoded by
plasmid pSH2-Arg35TAG) was carried out in LB medium in the
presence of tRNACUA and TcokRS, supplemented with 1 mM
ONBK. The estimated protein yield was over 6 mg L1 following
partial purication by affinity chromatography. The tandem
mass spectrometry data (Fig. S2, ESI†) conrmed the site-
specic incorporation of ONBK.
The affinity between the SH2-Arg35ONBK mutant and
a uorescein-labeled peptide probe was measured by uores-
cence polarization assay (Fig. 3). The peptide probe has the
exact amino acid sequence of the natural substrate of Src SH2
domain. The uorescein was conjugated to the peptide
substrate through a N-terminal glycine. As shown in Fig. 3B, the
caged SH2-Arg35ONBK bound to the peptide probe with very
low affinity (KD ¼ 4.972  0.436 mM). This result was consistent
with our hypothesis that a single Arg35 to ONBKmutation could
signicantly reduce the ability of SH2 domain to recognize pTyr.
Aer 15 minutes of UV (365 nm) irradiation, the SH2-
Arg35ONBK mutant displayed about 4-fold higher affinity
towards the peptide probe (KD¼ 1.273 0.533 mM; Fig. 3B). The
apparent KD values continued to decrease as the time of irra-
diation increased (Fig. 3B). A plateau (KD ¼ 0.690  0.053 mM)
was reached following 30 minutes of UV irradiation. Longer
irradiation time did not led to further increase in binding
affinity.
While the initial results showed that the function of the SH2-
Arg35ONBK mutant could be partially turned on by UV irradi-
ation, only 7.4-fold affinity enhancement was obtained. In
comparison to SH2-Arg35Lys (KD¼ 0.117 mM), the UV-irradiated
SH2-Arg35ONBK displayed a signicantly lower affinity (KD ¼
0.669  0.053 mM). To rule out potential damages of SH2
domain function caused by UV irradiation, the affinity between
SH2-Arg35Lys and the peptide probe was examined with and
without UV irradiation. No detectable effect by UV irradiation
was observed (Fig. S3, ESI†). Therefore, we hypothesized that
the low de-caging efficiency of ONBK was the limiting factor in
the restoration of SH2 domain function.
3.4 The second generation SH2 domain mutant
According to literature, a clean de-caging of ONBK that locates
on the surface of a GFP protein could be achieved within 20
minutes of UV irradiation.11 We hypothesized that a crowded
binding pocket containing chemically reactive amino acid side
chains could interfere with the de-caging reaction. In order to
improve the de-caging efficiency, we further engineered the
pTyr-binding pocket of the SH2-Arg35ONBK protein by intro-
ducing three mutations (Thr40Val, Cys45Ala, and Lys63Leu) to
afford SH2-Arg35ONBK-tm (Fig. 4). These mutations partially
opened up the binding pocket (Fig. 4) by substitution of amino
acids with side chains of relatively smaller sizes. In the mean-
time, three chemically reactive amino acid side chains (a
secondary alcohol, a thiol, and a primary amine) were removed.
As shown in Fig. 5, the SH2-Arg35ONBK-tm protein showed
signicantly lower affinity (KD > 15 mM) towards the peptide
substrate than that of SH2-Arg35ONBK (KD¼ 4.972 0.436 mM;
Fig. 3). It should be noted that the interaction between SH2-
Arg35ONBK-tm and the phosphopeptide was too weak to be
Fig. 4 Engineering of SH2 domain.
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accurately measured. The uorescence intensity values could
not reach a clear plateau even in the presence of very high
concentrations of protein. On the other hand, aer 60 minutes
of UV irradiation, the SH2-Arg35ONBK-tm protein displayed
signicantly higher affinity (KD ¼ 0.295 0.022 mM; Fig. 5) than
that of the irradiated SH2-Arg35ONBK. An at least 50-fold
change in affinity was observed before and aer UV irradiation.
Introduction of the three mutations (Thr40Val, Cys45Ala, and
Lys63Leu) into SH2-Arg35ONBK therefore lowered the back-
ground binding and increased signal output aer the UV irra-
diation. We attribute these improved properties of SH2-
Arg35ONBK-tm to following possible factors: (1) the Lys63Leu
mutation eliminates the electrostatic interaction between Lys63
in SH2-Arg35ONBK and a glutamate residue on the peptide
substrate (Fig. 3A and 4), which reduces the non-pTyr-
dependent interaction and leads to lower initial affinity of the
caged SH2 protein; (2) the Thr40Val, Cys45Ala, and Lys63Leu
mutations improve the affinity of de-caged SH2-Arg35ONBK-tm
towards phosphopeptide through the formation of a hydro-
phobic surface that engages the phenyl ring of the pTyr
residue;15 and (3) the bulky caging group efficiently prevents the
optimal interaction between the hydrophobic surface in caged
SH2-Arg35ONBK-tm and the phenyl ring of the pTyr residue in
phosphopeptide. The apparently additive effects of these factors
are translated into an excellent dynamic range in binding
affinities that are controlled by UV irradiation.
4. Conclusions
In summary, we have constructed the rst photoactivatable SH2
domain mutant, which can be potentially applied as a general
optogenetic tool to the photocontrol of pTyr-associated biolog-
ical processes. The protein engineering approach enabled us to
use a photo-caged lysine to mask and unmask the function of
a key arginine residue of SH2 domain. Additional engineering
efforts will be made towards further improving the property of
the obtained photoactivatable SH2 domain mutant. Other
photo-caging groups will also be examined. The approaches and
ndings from this work are likely applicable to the engineering
of other photoactivatable SH2 domains.
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I. List of Primers. 
 
P1 5’-GGAGATATACATATGGACTCCATCCAGGCTGAGGAG -3’ 
P2 5’-CACGAGGAAGGTCCCTCT-3’ 
P3 5’-AGAGGGACCTTCCTCGTGTAGGAAAGTGAGACCACGA-3’ 
P4 5’-AGTTATTGCTCAGCGGTGGCAG-3’ 
P5 5’-AGAGGGACCTTCCTCGTGAAAGAAAGTGAGACCACGA-3’ 
P6 5’-GTGCGAGAAAGTGAGACCGTGAAAGGTGCCTACGCGCTCTCAGTGTCTGACTTC-3’ 
P7 5’-GAAGTCAGACACTGAGAGCGCGTAGGCACCTTTCACGGTCTCACTTTCTCGCAC-3’ 
P8 5’-CCTCAACGTGAAGCACTACCTGATCCGCAAGCTGGACAGC-3’ 
P9 5’-GCTGTCCAGCTTGCGGATCAGGTAGTGCTTCACGTTGAGG-3’ 
 
 3 
II. Synthesis of ONBK 
 
 
 
2-Nitrobenzyl-N-succinimidyl carbonate (ONB-NHS) was synthesized by following a reported 
procedure.1  To the solution of ONB-NHS (688mg, 2.34 mmol) in dimethylformamide (11.7 mL) 
was added Nα-(tert-butoxycarbonyl)-L-lysine (634mg, 2.57 mmol).  After the mixture was stirred 
at room temperature overnight, 40 mL of ethyl acetate was added.   The resulting mixture was 
washed with water and brine (three times) to remove DMF.  The organic layer was concentrated 
under vacuum.  Purification by silica-gel flash chromatography (1% acetic acid and 33% to 66% 
ethyl acetate in hexane as gradient) afforded Boc-protected ONBK as a white solid (1.221 g).  
The Boc-protected ONBK was then dissolved in 4 mL of 1,4-dioxane and 10 mL of 4 N HCl 
solution in 1,4-dioxane was added dropwise.  The reaction was stirred at room temperature for 3 
hours.  The white solid precipitation was collected by vacuum filtration and washed with diethyl 
ether.  ONBK (0.772 g) was obtained as a white powder in 99% yield from ONB-NHS.  1H-NMR 
(300 MHz, DMSO-d6): δ ppm: 13.76 (bs, 1 H), 8.35 (bs, 2 H), 8.11 (d, J = 8.1 Hz, 1 H), 7.81 (m, 
1 H), 7.67-7.58 (m, 2 H), 7.47 (s, 1 H), 5.36 (s, 2 H), 3.85 (m, 1 H), 2.99 (m, 2 H), 1.79-1.77 (m, 
2 H), 1.5-1.20 (m, 2 H).  13C-NMR (400 MHz, DMSO-d6): δ ppm: 170.9, 155.5, 147.1, 134.0, 
132.9, 128.8, 138.7, 124.7, 66.3, 61.8, 51.7, 29.5, 28.7, 21.5.  The NMR spectra can be found in 
Fig. S4 and Fig. S5.  MS (LCQ): calcd for C14H20N3O6 ([M+H]+), 326.3;  Found, 326.3. 
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III. Additional data 
 
 
 
Fig. S1 GFPUV fluorescence assays.   
Fluorescence intensity was normalized to cell growth. 
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Fig. S2 Mass spectrometry analysis of SH2 domain mutant containing ONBK at position 35.   
The y ions are marked in the spectrum.  The amino acid sequence of the peptide fragment, 
GTFLV-ONBK-ESETTK, from SH2 domain mutant containing ONBK is shown on top. 
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Fig. S3 Recognition of the phosphopeptide probe by the SH2-Arg35Lys mutant with and without 
30 minutes of UV irradiation. 
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Fig. S4 1H NMR of ONBK. 
Chemical shifts are reported (in parts per million) relative to internal tetramethylsilane (δ = 0.0 
ppm) with DMSO-d6 as solvent. 
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Fig. S5 13C NMR of ONBK. 
Chemical shifts are reported (in parts per million) relative to internal tetramethylsilane (δ = 0.0 
ppm) with DMSO-d6 as solvent. 
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